Correlation Between Inozyme Pharma and Amgen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and Amgen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and Amgen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and Amgen Inc, you can compare the effects of market volatilities on Inozyme Pharma and Amgen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of Amgen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and Amgen.

Diversification Opportunities for Inozyme Pharma and Amgen

-0.72
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Inozyme and Amgen is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and Amgen Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amgen Inc and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with Amgen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amgen Inc has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and Amgen go up and down completely randomly.

Pair Corralation between Inozyme Pharma and Amgen

Given the investment horizon of 90 days Inozyme Pharma is expected to under-perform the Amgen. In addition to that, Inozyme Pharma is 2.03 times more volatile than Amgen Inc. It trades about -0.22 of its total potential returns per unit of risk. Amgen Inc is currently generating about 0.22 per unit of volatility. If you would invest  28,655  in Amgen Inc on December 4, 2024 and sell it today you would earn a total of  2,613  from holding Amgen Inc or generate 9.12% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Inozyme Pharma  vs.  Amgen Inc

 Performance 
       Timeline  
Inozyme Pharma 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Inozyme Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Amgen Inc 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Amgen Inc are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of very conflicting technical and fundamental indicators, Amgen displayed solid returns over the last few months and may actually be approaching a breakup point.

Inozyme Pharma and Amgen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Inozyme Pharma and Amgen

The main advantage of trading using opposite Inozyme Pharma and Amgen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, Amgen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amgen will offset losses from the drop in Amgen's long position.
The idea behind Inozyme Pharma and Amgen Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Fundamental Analysis
View fundamental data based on most recent published financial statements
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Commodity Directory
Find actively traded commodities issued by global exchanges